UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)		March 22, 2007
GENELABS TECHNOLOGIES, INC.
(Exact Name of Registrant as Specified in Charter)
California	0-19222		94-3010150
(State or other jurisdiction of incorporation)	(Commission File Number)		(IRS Employer Identification No.)
505 Penobscot Drive, Redwood City, California			94063
(Address of principal executive offices)			(Zip Code)
Registrant’s telephone number, including area code			(650) 369-9500
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02 Results of Operations and Financial Condition.

On March 22, 2007, Genelabs Technologies, Inc. announced its financial results for the fourth quarter and year ended December 31, 2006. A copy of the related press release is furnished as Exhibit 99.1 hereto.

The information in this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

(c) Exhibits

Exhibit Number	Description
99.1	Press Release, dated March 22, 2007, entitled “Genelabs Technologies Reports 2006 Year-End and Fourth Quarter Financial Results”

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

GENELABS TECHNOLOGIES, INC.

By: /s/ James A.D. Smith

Name: James A.D. Smith

Title: President and Chief Executive Officer

Date: March 27, 2007

EXHIBIT INDEX

Exhibit Number	Description
99.1	Press Release, dated March 22, 2007, entitled “Genelabs Technologies Reports 2006 Year-End and Fourth Quarter Financial Results”